期刊文献+

ANPT2238C,C-664G Gene Polymorphism and Coronary Heart Diseasein Chinese Population

ANPT2238C,C-664G Gene Polymorphism and Coronary Heart Diseasein Chinese Population
下载PDF
导出
摘要 The association between atrial natriuretic peptide (ANP) polymorphism and coronary heart disease (CHD) was studied in Chinese population. The genotypes of ANP T2238C and ANP C-664G were detected by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) methods in 158 consecutive CHD patients and 165 controls. It was found that the distribution of A2A2 genotype in CHD group was significantly higher than that in control group (P〈0.05). Stepwise Logistic regression analysis revealed that male, smoking, history of hypertension, history of diabetes, family history of hypertension, high level of serum cholesterol, and ANP T2238C polymorphism were the possible risk factors in patients with CHD (P〈0.05). However, there was no significant difference between the patients with CHD and the control group in the distribution of ANP C-664G polymorphism (P〉0.05). The results suggest that A2A2 T2238C genotype could be one of the risk factors for CHD (P〈0.05, OR: 1.80, 95 % CI: 1.03-3.15). The association between atrial natriuretic peptide (ANP) polymorphism and coronary heart disease (CHD) was studied in Chinese population. The genotypes of ANP T2238C and ANP C-664G were detected by polymerase chain reaction and restriction fragment length polymorphism (PCR-RFLP) methods in 158 consecutive CHD patients and 165 controls. It was found that the distribution of A2A2 genotype in CHD group was significantly higher than that in control group (P〈0.05). Stepwise Logistic regression analysis revealed that male, smoking, history of hypertension, history of diabetes, family history of hypertension, high level of serum cholesterol, and ANP T2238C polymorphism were the possible risk factors in patients with CHD (P〈0.05). However, there was no significant difference between the patients with CHD and the control group in the distribution of ANP C-664G polymorphism (P〉0.05). The results suggest that A2A2 T2238C genotype could be one of the risk factors for CHD (P〈0.05, OR: 1.80, 95 % CI: 1.03-3.15).
出处 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2006年第5期528-530,共3页 华中科技大学学报(医学英德文版)
基金 This project was supported by a grant from National Natural Sciences Foundation of China (No.30128021).
关键词 coronary heart disease atrial natriuretic peptide POLYMORPHISM coronary heart disease atrial natriuretic peptide polymorphism
  • 相关文献

参考文献6

  • 1Umesh Masharani,Philip F. Nakashima,Don W. Lim,Philippe M. Frossard.NsiI andScaI restriction fragment length polymorphisms at the atrial natriuretic peptides (ANP) gene locus[J].Human Genetics.1988(3)
  • 2Nishikimi T,Mori Y,Ishimura K et al.Association of plasma atrial natriuretic peptide, N-terminal proatrial natri-uretic peptide, and brain natriuretic peptide levels with coronary artery stenosis in patients with normal left ventricular systolic function[].The American Journal of Medicine.2004
  • 3Takagi G,Kiuchi K,Endo T et al.Alpha-human atrial natriuretic peptide, carperitide, reduces infarct size but not arrhythmias after coronary occlusion/reperfusion in dogs[].Journal of Cardiovascular Pharmacology.2000
  • 4Kato N,Sugiyama T,Morita H et al.Genetic analysis of the atrial natriuretic peptide gen in essential hypertension[].Clinical Science.2000
  • 5Gruchala M,Ciecwierz D,Wasag B et al.Association of the ScaI atrial natriuretic peptide gene polymorphism with nonfatal myocardial infarction and extent of coronary artery disease[].American Heart Journal.2003
  • 6Scott M,Gary J,Michael H et al.Primary prevention of coronary heart disease: Guidance from framingham[].Circulation.1998

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部